| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/17/2012 | CA2353535C Patterned binding of functionalized microspheres for optical diffraction-based biosensors |
| 01/17/2012 | CA2353419C Patterned deposition of antibody binding proteins for optical diffraction-based biosensors |
| 01/15/2012 | CA2714714A1 Screening, assessing and monitoring an eye disease and/or condition using urinary biomarkers |
| 01/12/2012 | WO2012006618A2 Optical measurement of an analyte |
| 01/12/2012 | WO2012006617A2 Optical analyte measurement |
| 01/12/2012 | WO2012006603A2 Clickable cross-linker |
| 01/12/2012 | WO2012006589A2 Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling |
| 01/12/2012 | WO2012006540A2 Improving the efficiency of prion conversion in vitro and sensitivity of prion detection |
| 01/12/2012 | WO2012006534A2 Methods, compositions and kits for diagnosing and treating alzheimer's disease using mitochondrial co3 gene mutations |
| 01/12/2012 | WO2012006497A2 Mu opioid receptor agonist analogs of the endomorphins |
| 01/12/2012 | WO2012006490A2 Dual variable domain immunoglobulins and uses thereof |
| 01/12/2012 | WO2012006476A2 Methods and compositions for quantifying exosomes |
| 01/12/2012 | WO2012006421A2 Diagnosis and treatment of breast cancer |
| 01/12/2012 | WO2012006406A2 Analyte mass spectrometry quantitation using a universal reporter |
| 01/12/2012 | WO2012006394A2 Hmga2 as a biomarker for diagnosis and prognosis of ovarian cancer |
| 01/12/2012 | WO2012006391A2 Modulators for sirt5 and assays for screening same |
| 01/12/2012 | WO2012006240A1 Novel catalyst mixtures |
| 01/12/2012 | WO2012006187A2 Methods and devices for the selective detection of microorganisms |
| 01/12/2012 | WO2012006084A2 Systems and methods for transfer of liquid samples |
| 01/12/2012 | WO2012005969A1 Apparatus and method for determining analyte content in a fluid |
| 01/12/2012 | WO2012005857A1 Nanopore device with graphene supported artificial lipid membrane |
| 01/12/2012 | WO2012005844A2 Optical method for determining fouling of crude and heavy fuels |
| 01/12/2012 | WO2012005838A1 Analyte mass spectrometry quantitation using a universal reporter |
| 01/12/2012 | WO2012005719A2 Oral health index |
| 01/12/2012 | WO2012005696A1 Apparatus and method for predicting a parameter in the blood stream of a subject |
| 01/12/2012 | WO2012005680A1 Methods for determination of ethanol consumption |
| 01/12/2012 | WO2012005606A1 Methods and kits for infertility testing |
| 01/12/2012 | WO2012005588A2 Novel biomarkers for detecting neuronal loss |
| 01/12/2012 | WO2012005570A1 Gas sampling for co2 assay |
| 01/12/2012 | WO2012005563A1 Uses of biological compounds from toxoplasma sp and related compounds |
| 01/12/2012 | WO2012005379A1 Transformant obtained by introducing gm1 gene and crmp2 gene |
| 01/12/2012 | WO2012005339A1 Prophylactic or therapeutic agent for diabetes |
| 01/12/2012 | WO2012005238A1 Method for detection of infection with human cytomegalovirus |
| 01/12/2012 | WO2012004822A1 Use of melanoma biomarkers in medical and diagnostic field and method for the identification thereof |
| 01/12/2012 | WO2012004790A2 Nucleic acid aptamer-based diagnostic methods with novel techniques for signal enhancement |
| 01/12/2012 | WO2012004778A1 Method for in-vitro monitoring of neuronal disorders and use thereof |
| 01/12/2012 | WO2012004723A1 Examination system with sample incubation |
| 01/12/2012 | WO2012004721A1 A planar support having an ultraflat surface and a device for detecting antigens comprising said planar support |
| 01/12/2012 | WO2012004635A1 Methods of making a diagnostic composition and compositions therefrom |
| 01/12/2012 | WO2012004612A1 Low volume assay apparatus |
| 01/12/2012 | WO2012004611A1 Therapeutic use of neural stem cells |
| 01/12/2012 | WO2012004566A1 Method for diagnosis |
| 01/12/2012 | WO2012004565A1 Cancer biomarker brf1 |
| 01/12/2012 | WO2012004559A1 Methods for screening for compounds expected to be useful in the modulating, for example inhibiting, the activity of kiaa1018/mtmr15/fan1. |
| 01/12/2012 | WO2012004540A1 Method for the detection and direct identification of a microorganism in a biological sample diluted in an enrichment broth |
| 01/12/2012 | WO2012004536A1 Colormetric device for detecting, in an aqueous solution of interest, hydrolytic enzymatic activity with regard to at least one polymer of interest |
| 01/12/2012 | WO2012004372A1 Prognostic or diagnostic method and kit associated with cases of postpartum haemorrhages |
| 01/12/2012 | WO2012004371A2 Biomarker for hypertensive disorders of pregnancy |
| 01/12/2012 | WO2012004354A1 Allowing measurements to be made of a blood sample |
| 01/12/2012 | WO2012004310A1 Adipose tissue model and preparation process |
| 01/12/2012 | WO2012004301A1 Markers of vulnerability of the atherosclerosis plaque |
| 01/12/2012 | WO2012004276A2 Multiprotein biomarkers of amyotrophic lateral sclerosis in peripheral blood mononuclear cells, diagnostic methods and kits |
| 01/12/2012 | WO2012004143A1 Method for correcting the pump voltage of a sensor element |
| 01/12/2012 | WO2012004062A1 Method for active hybridization in microarrays with denaturing function |
| 01/12/2012 | WO2012003980A1 Device and method for the in situ characterization of quality parameters and/or the properties of inorganic binder systems |
| 01/12/2012 | WO2012003955A1 Fluorescent carbapenems |
| 01/12/2012 | WO2012003817A1 Novel method for characterizing and multi-dimensionally representing the folding process of proteins |
| 01/12/2012 | WO2012003805A1 Body fluid inspection device |
| 01/12/2012 | WO2012003617A1 Immuno-chromatographic detection device and detection method thereof |
| 01/12/2012 | WO2011153590A8 Use of interferon epsilon in methods of diagnosis and treatment |
| 01/12/2012 | WO2011146945A3 Alk and ros kinase in cancer |
| 01/12/2012 | WO2011146636A3 Reagents and methods for sirtuin capture |
| 01/12/2012 | WO2011145629A3 ANTIBODY CAPABLE OF BINDING TO TRANSFORMING GROWTH FACTOR ALPHA AND HAVING ANTIPROLIFERATIVE ACTIVITY ON CANCER HAVING Ras GENE MUTATION |
| 01/12/2012 | WO2011140030A3 System and method for measuring the ratio of forward-propagating to back-propagating second harmonic-generation signal, and applications thereof |
| 01/12/2012 | WO2011134670A3 Diagnostic method for predicting the response of a patient to chemovirotherapy or radiovirotherapy |
| 01/12/2012 | WO2011129710A4 Microarrays |
| 01/12/2012 | WO2011129427A9 Diagnostic agent and therapeutic agent for cancer |
| 01/12/2012 | WO2011121097A3 Method and device for analysing molecular bonds |
| 01/12/2012 | WO2011119962A3 Microfluidic enrichment of selected cell populations |
| 01/12/2012 | WO2011116353A3 Method for regulating survival and memory of t helper 1 cells |
| 01/12/2012 | WO2011116256A3 Multiphase microarrays and uses thereof |
| 01/12/2012 | WO2011112908A3 Optical particle characterization system |
| 01/12/2012 | WO2011112749A3 Semi-invasive method for characterizing lung injury |
| 01/12/2012 | WO2011112023A3 Chip for separating blood cells |
| 01/12/2012 | WO2011109832A3 Methods and compositions for nmr spectroscopic analysis using isotopic labeling schemes |
| 01/12/2012 | WO2011109830A9 Protein biomarkers and therapeutic targets for renal disorders |
| 01/12/2012 | WO2011109556A3 Method for producing soluble recombinant interferon protein without denaturing |
| 01/12/2012 | WO2011109368A3 Patterning of biomaterials using fluorinated materials and fluorinated solvents |
| 01/12/2012 | WO2011106373A3 Arnt isoform 3 as a predictor of aminoflavone responsiveness in cancer cells |
| 01/12/2012 | WO2011106363A3 Metabolic rate indicator for cellular populations |
| 01/12/2012 | WO2011106088A3 Systems and methods for evaluating asphaltene deposition inhibitors |
| 01/12/2012 | WO2011105826A3 Method using camp expression measurement to diagnose prostate inflammation, and diagnostic kit |
| 01/12/2012 | WO2011105732A3 Method and kit for detecting egfr mutation by using pna-based real-time pcr clamping |
| 01/12/2012 | WO2011103502A3 Materials and methods for profiling micrornas |
| 01/12/2012 | WO2011100669A3 Lable-free multiplexing bioassays using fluorescent conjugated polymers and barcoded nanoparticles |
| 01/12/2012 | WO2011099730A3 Method for identifying modulators that modulate physiological functions of intracellular components within a cell |
| 01/12/2012 | WO2011062469A8 Diagnostic method for detecting acute kidney injury using heat shock protein 72 as a sensitive biomarker |
| 01/12/2012 | US20120010823 System for the quantification of system-wide dynamics in complex networks |
| 01/12/2012 | US20120010750 Device and method for testing the cleaning effect of a cleaning apparatus |
| 01/12/2012 | US20120010597 Induction of dendritic cell development with macrophage-colony stimulating factor (m-csf) |
| 01/12/2012 | US20120010592 Diabetes care management system |
| 01/12/2012 | US20120010487 Systems and methods for monitoring health and delivering drugs transdermally |
| 01/12/2012 | US20120010389 Detection of specific nitrated markers |
| 01/12/2012 | US20120010274 Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof |
| 01/12/2012 | US20120010270 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN TUMOR SUPPRESSING SUBTRANSFERABLE CANDIDATE 6 (TSSC6) |
| 01/12/2012 | US20120010269 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN SMS3 |
| 01/12/2012 | US20120010268 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN ACHAETE-SCUTE HOMOLOG 2 (HASH2) |
| 01/12/2012 | US20120010266 Tbc1d7 as tumor marker and therapeutic target for cancer |
| 01/12/2012 | US20120010240 CUT-POINT IN PTEN PROTEIN EXPRESSION THAT ACCURATELY IDENTIFIES TUMORS AND IS PREDICTIVE OF DRUG RESPONSE TO A PAN-ErbB INHIBITOR |
| 01/12/2012 | US20120010234 Use of vegf-d in the diagnosis of lymphangioleiomyomatosis (lam) disease |